Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexaria Bioscience (LEXX) Leases (2020 - 2025)

Lexaria Bioscience's Leases history spans 6 years, with the latest figure at $99485.0 for Q4 2025.

  • For Q4 2025, Leases fell 22.29% year-over-year to $99485.0; the TTM value through Nov 2025 reached $99485.0, down 22.29%, while the annual FY2025 figure was $106816.0, 20.78% down from the prior year.
  • Leases for Q4 2025 was $99485.0 at Lexaria Bioscience, down from $106816.0 in the prior quarter.
  • Across five years, Leases topped out at $178127.0 in Q2 2023 and bottomed at $32047.0 in Q1 2023.
  • The 5-year median for Leases is $108061.0 (2021), against an average of $107163.6.
  • The largest annual shift saw Leases tumbled 55.55% in 2023 before it surged 368.05% in 2024.
  • A 5-year view of Leases shows it stood at $81656.0 in 2021, then crashed by 48.15% to $42340.0 in 2022, then skyrocketed by 269.78% to $156565.0 in 2023, then fell by 18.23% to $128025.0 in 2024, then dropped by 22.29% to $99485.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Leases are $99485.0 (Q4 2025), $106816.0 (Q3 2025), and $114015.0 (Q2 2025).